In a recent meeting held in Highland, Utah, Kirk Moore shared his experiences and insights on treating patients with COVID-19, particularly focusing on the use of monoclonal antibodies and steroids. His narrative highlighted the challenges faced by patients in accessing timely and effective treatment during the pandemic.

Moore recounted a specific case involving a patient named Chris, who struggled with low oxygen saturation levels and had been ill for over a week. Initially, Chris was denied monoclonal antibody treatment due to strict eligibility criteria that excluded him based on his skin color and perceived severity of illness. This incident underscores the complexities and potential inequities in healthcare access during critical times.

After Chris's condition worsened, Moore took decisive action by administering high doses of steroids, specifically Solu Medrol, which he had to research and learn about quickly. His approach was guided by the FLCCC protocol, which emphasizes the importance of timely and appropriate treatment for COVID-19 patients. Moore's persistence paid off; after adjusting the dosage and closely monitoring Chris's condition, he reported significant improvement in Chris's oxygen levels, ultimately leading to his recovery.

Moore's experience reflects a broader trend of healthcare providers adapting their practices in response to the pandemic. He noted that he began treating more patients in his office rather than making house calls, as demand for treatment increased. This shift allowed him to implement a structured treatment regimen, including intravenous steroids and high-dose vitamin C, without charging patients for the medications or nursing staff time.

The meeting served as a platform for Moore to advocate for more accessible and effective treatment options for COVID-19 patients. His story illustrates the critical role of healthcare professionals in navigating the challenges posed by the pandemic and highlights the need for ongoing discussions about treatment protocols and healthcare equity.

As the community continues to grapple with the aftermath of COVID-19, Moore's insights may inspire further dialogue on improving patient care and ensuring that all individuals have access to necessary treatments. The meeting concluded with a call for continued collaboration among healthcare providers to enhance treatment strategies and address the evolving needs of patients in Utah.